Background and Purpose: Outcome prognostication in ischemic stroke patients remains
challenging due to limited predictive properties of existing models. Blood-based biomarkers …

Cardiac complications are a frequent medical problem during the first few days after an
ischaemic stroke, and patients present with a broad range of symptoms including myocardial …

Background and Purpose—Stroke diagnosis could be challenging in the acute phase. We
aimed to develop a blood-based diagnostic tool to differentiate between real strokes and …

Background and Purpose—Determining the underlying cause of stroke is important to
optimize secondary prevention treatment. Increased blood levels of natriuretic peptides (B …

BNGF indicates B-type neutrotrophic growth factor; BNP, brain natriuretic peptide; CCR7,
chemokine receptor 7; EGFR, epidermal growth factor receptor; IL, interleukin; MCP-1 …

There has been a large confirmation over the last decades that stroke may produce cardiac
changes (echocardiographic, electrocardiographic, enzymatic). In ischemic stroke, systolic …

Background Epileptic seizures (ES) lead to alterations in the blood laboratory values and
reflect changes in different organ systems. Here, we review the diagnostic and prognostic …

We aimed to quantify the association of blood interleukin-6 (IL-6) concentrations with poor
outcome after stroke and its added predictive value over clinical information. Meta-analysis …

Background and Purpose—Improved identification of those at risk of stroke might improve
prevention. We evaluated the association of the cardiac function biomarker N-terminal pro–B …

Introduction Individual participant data (IPD) systematic reviews and meta-analyses are
often considered to be the gold standard for meta-analysis. In the ten years since the first …